Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph F Merola

Showing results (251-260 of 394) with videos related to

Pageof 40
Sort By:
Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2025
Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc AnalysesKenneth B Gordon, Joseph F Merola, Peter Foley, et al.
RMD Open|September 23, 2024
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studiesM Elaine Husni, Philip J Mease, Joseph F Merola, et al.
Journal of the American Academy of Dermatology|May 3, 2021
Lack of association between tumor necrosis factor-α inhibitor use and exacerbation of lupus erythematosus: A retrospective cohort studyMichelle S Min, Bina Kassamali, Daniel R Mazori, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 19, 2020
Coronary microvascular dysfunction in patients with psoriasisBrittany Weber, Lourdes M Perez-Chada, Sanjay Divakaran, et al.
Rheumatology (Oxford, England)|February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritisDennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.
Journal of the American Academy of Dermatology|April 2, 2013
Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosusJoseph F Merola, Stephen D Prystowsky, Christina Iversen, et al.
Rheumatology and Therapy|March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three IndicationsJoseph F Merola, Iain B McInnes, Atul A Deodhar, et al.
Journal of the American Academy of Dermatology|December 10, 2014
The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatologyAlice B Gottlieb, Adriane A Levin, April W Armstrong, et al.
Rheumatology and Therapy|July 24, 2020
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population SurveyWilliam Tillett, Joseph F Merola, Diamant Thaçi, et al.
Pageof 40

Showing results (251-260 of 394) with videos related to

Sort By:
Pageof 40
Dermatology (Basel, Switzerland)|August 20, 2018
Are Your Patients Satisfied A Systematic Review of Treatment Satisfaction Measures in PsoriasisNicole Salame, Lourdes M Perez-Chada, Sanminder Singh, et al.
Journal of Drugs in Dermatology : JDD|February 6, 2025
Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc AnalysesKenneth B Gordon, Joseph F Merola, Peter Foley, et al.
RMD Open|September 23, 2024
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studiesM Elaine Husni, Philip J Mease, Joseph F Merola, et al.
Journal of the American Academy of Dermatology|May 3, 2021
Lack of association between tumor necrosis factor-α inhibitor use and exacerbation of lupus erythematosus: A retrospective cohort studyMichelle S Min, Bina Kassamali, Daniel R Mazori, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 19, 2020
Coronary microvascular dysfunction in patients with psoriasisBrittany Weber, Lourdes M Perez-Chada, Sanjay Divakaran, et al.
Rheumatology (Oxford, England)|February 11, 2024
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritisDennis McGonagle, Arthur Kavanaugh, Iain B McInnes, et al.
Journal of the American Academy of Dermatology|April 2, 2013
Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosusJoseph F Merola, Stephen D Prystowsky, Christina Iversen, et al.
Rheumatology and Therapy|March 19, 2022
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three IndicationsJoseph F Merola, Iain B McInnes, Atul A Deodhar, et al.
Journal of the American Academy of Dermatology|December 10, 2014
The International Dermatology Outcome Measures Group: formation of patient-centered outcome measures in dermatologyAlice B Gottlieb, Adriane A Levin, April W Armstrong, et al.
Rheumatology and Therapy|July 24, 2020
Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population SurveyWilliam Tillett, Joseph F Merola, Diamant Thaçi, et al.
Pageof 40